Showing results (471-480 of 518) with videos related to
Sort By:
Pageof 52
The Journal of Infectious Diseases|August 1, 1983
Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agentsD W Bradley, J E Maynard, H Popper, et al.Scandinavian Journal of Rheumatology|January 1, 1997
The effect of HLA-DRB1 disease susceptibility markers on the expression of RAM J Rowley, A Stockman, C A Brand, et al.Journal of Gastroenterology|February 1, 1996
Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosisK Omagari, M J Rowley, J A Jois, et al.Clinical Immunology and Immunopathology|February 1, 1995
Differing frequency of autoantibodies to glutamic acid decarboxylase among Koreans, Thais, and Australians with diabetes mellitusT Tuomi, P Zimmet, M J Rowley, et al.The Journal of Infectious Diseases|December 1, 1981
Non-A, non-B hepatitis in chimpanzees and marmosetsS M Feinstone, H J Alter, H P Dienes, et al.Hepatology (Baltimore, Md.)|March 1, 1981
Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologic with virologic observationsH Popper, J W Shih, J L Gerin, et al.Archives of Pathology & Laboratory Medicine|November 9, 2006
Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fibrous tumors and assessment of beta-catenin and cyclin D1 expressionLizmarie Andino, Philip T Cagle, Bruno Murer, et al.International Angiology : a Journal of the International Union of Angiology|March 24, 2011
The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemiaJ J F Belch, S Ray, M Rajput-Ray, et al.Lung Cancer (Amsterdam, Netherlands)|December 23, 2008
The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets?Elvira Stacher, Ulrike Gruber-Mösenbacher, Iris Halbwedl, et al.Blood|August 1, 1985
A study of liver biopsies and liver disease among hemophiliacsL M Aledort, P H Levine, M Hilgartner, et al.Pageof 52